Generally, a few injections of Ropilastin/Romilastin are effective.

The therapeutic effects of Romiplostim usually require multiple injections to develop. In the treatment of immune thrombocytopenia (ITP), loplastin is not effective in one shot, but requires a period of treatment to achieve the expected platelet-increasing effect.

For most patients, treatment typically begins with weekly injections, with specific treatment cycles adjusted based on patient response. Initially, patients will typically see a gradual increase in platelet counts over the course of four to six weeks of treatment. Although the rate of response varies from patient to patient, most patients will see significant platelet increases within a few weeks of treatment. According to clinical experience, patients usually see a significant increase in platelet count after receiving 4 to 6 injections of treatment, and some patients can even reach ideal platelet levels after the 1st to 2nd injection of treatment.

Treatment with Roprostim does not stop with a simple injection, it also involves adjusting the dose and frequency of treatment based on changes in platelet counts. If the patient's platelet count remains relatively stable during treatment, the doctor may gradually reduce the frequency or dose of injections. Typically, the frequency of injections may be adjusted from once a week to once every two weeks while the platelet count remains within the target range.

However, continuity of treatment remains critical. Although some patients are able to see significant improvements in their platelet counts after just a few shots, to ensure the long-term effectiveness of the treatment and to maintain stable platelet levels, it is usually necessary to continue treatment and regularly monitor platelet levels. In general, many patients may require at least several months of treatment to ensure stable platelet levels and reduce the risk of recurrence.

Reference materials:https://en.wikipedia.org/wiki/Romiplostim